HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

SB 216763

a glycogen synthase kinase-3 inhibitor; structure in first source
Also Known As:
3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; SB-216763; SB216763
Networked: 98 relevant articles (6 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Ren, Feng: 4 articles (01/2015 - 07/2011)
2. Gross, Eric R: 3 articles (01/2015 - 08/2006)
3. Gross, Garrett J: 3 articles (01/2015 - 08/2006)
4. Hsu, Anna K: 3 articles (01/2015 - 08/2006)
5. Cohen, Michael V: 3 articles (12/2010 - 07/2006)
6. Downey, James M: 3 articles (12/2010 - 07/2006)
7. Zhang, Jing: 2 articles (01/2021 - 11/2014)
8. He, Kang: 2 articles (04/2019 - 01/2018)
9. Hua, Xiangwei: 2 articles (04/2019 - 01/2018)
10. Xia, Qiang: 2 articles (04/2019 - 01/2018)

Related Diseases

1. Ischemia
2. Vomiting
3. Infarction (Infarctions)
4. Sepsis (Septicemia)
5. Hemorrhage

Related Drugs and Biologics

1. Lithium
2. Glycogen Synthase Kinase 3
3. N- (4- methoxybenzyl)- N'- (5- nitro- 1,3- thiazol- 2- yl)urea
4. Serotonin (5 Hydroxytryptamine)
5. Antiemetics
6. Small Interfering RNA (siRNA)
7. 2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- one
8. Inflammasomes
9. Therapeutic Uses
10. 5-HT3 Serotonin Receptors (5 HT3 Receptor)

Related Therapies and Procedures

1. Therapeutics
2. Intraperitoneal Injections
3. Ischemic Postconditioning
4. Resuscitation
5. Punctures